IP

Iok-Hou Pang

AL Alcon: 7 patents #120 of 866Top 15%
AL Alcon Laboratories: 3 patents #82 of 314Top 30%
AM Alcon Manufacturing: 3 patents #16 of 72Top 25%
AR Alcon Research: 3 patents #64 of 267Top 25%
SG Shire Orphan Therapies Gmbh: 2 patents #16 of 28Top 60%
AP Astellas Pharma: 1 patents #544 of 954Top 60%
📍 Grand Prairie, TX: #8 of 352 inventorsTop 3%
🗺 Texas: #7,287 of 125,132 inventorsTop 6%
Overall (All Time): #239,233 of 4,157,543Top 6%
19
Patents All Time

Issued Patents All Time

Showing 1–19 of 19 patents

Patent #TitleCo-InventorsDate
9822147 Methods of treating ophthalmic diseases using NPR-B agonists Mark R. Hellberg 2017-11-21
9187525 Methods of treating ophthalmic diseases using NPR-B agonists Mark R. Hellberg 2015-11-17
8551938 NPR-B agonists Mark R. Hellberg 2013-10-08
8252793 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma Keith Combrink, Suchismita Mohapatra, Mark R. Hellberg, Najam A. Sharif, Ganesh Prasanna +3 more 2012-08-28
7838507 RNAi inhibition of CTGF for treatment of ocular disorders Allan R. Shepard 2010-11-23
7803824 Use of inhibitors of Jun N-terminal kinases to treat glaucoma Debra L. Fleenor 2010-09-28
7625927 Method of treating glaucoma Peter G. Klimko 2009-12-01
7622454 RNAi inhibition of CTGF for treatment of ocular disorders Allan R. Shepard 2009-11-24
7598288 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma Mark R. Hellberg, Abbot F. Clark, Peggy Hellberg, Loretta McNatt, Wan-Heng Wang 2009-10-06
7488723 Use of non-feminizing estrogens as treatment for retinal vascular diseases 2009-02-10
7384926 Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma Abbot F. Clark 2008-06-10
7351407 Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies Debra L. Fleenor, Allan R. Shepard, Nasreen Jacobson, Abbot F. Clark 2008-04-01
7005446 Use of AP-1 activators to treat glaucoma and ocular hypertension Debra Shade, Abbot F. Clark 2006-02-28
6906077 Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases 2005-06-14
6444676 Use of PARP inhibitors in the treatment of glaucoma Abbot F. Clark 2002-09-03
6399058 Methods for treating ocular diseases 2002-06-04
6303579 Use of calpain inhibitors to treat ocular neural pathology Michael A. Kapin, Louis DeSantis, Jr. 2001-10-16
5965534 Use of .omega.-conotoxin analogs for treating retinal and optic nerve head damage Michael A. Kapin, Mark R. Hellberg 1999-10-12
5681854 Use of aliphatic carboxylic acid derivatives in ophthalmic disorders Michael A. Kapin 1997-10-28